Target intelligence / Profile preview

Zinc finger protein 322 pseudogene 1 (ZNF322P1)

Target
ZNF322P1
Molecular classification
Pseudogene, Non-coding RNA (potential, if transcribed), Related to zinc finger protein family (by annotation/sequence; but does not produce protein)
01

Overview

Zinc finger protein 322 pseudogene 1 (ZNF322P1) is classified as a pseudogene in the human genome, named for its sequence similarity to zinc finger protein 322 (ZNF322). Unlike protein-coding members of the zinc finger protein family, ZNF322P1 is unable to produce a functional protein due to mutations or sequence disruptions and is not considered a biologically active molecule or clinical drug target. Zinc finger proteins generally function as transcription factors, regulating gene expression and participating in critical cellular roles—including metabolism, apoptosis, and differentiation. However, ZNF322P1 lacks these functions as a pseudogene. For structured biological databases, ZNF322P1 should not be considered an actionable therapeutic target. If a functional zinc finger protein or transcription factor was intended, entry should be revised to refer to the protein-coding gene, such as “Zinc finger protein 322” (ZNF322A).

Other names
ZNF322P1Zinc finger protein 322 pseudogene 1ZNF322ZNF322B
02

Mechanism of action

Not applicable, as it is not a functional protein or validated drug target.

03

Biological functions

None established for this pseudogene itself.Related functional genes (such as ZNF322A) are transcription factors involved in transcriptional regulation, but ZNF322P1 itself has no confirmed function as a protein.
04

Disease associations

None established. There is currently no evidence associating ZNF322P1 with disease processes.
05

Safety considerations

None. As a non-functional pseudogene, safety or therapeutic targeting issues are not applicable.
06

Interacting drugs

None. No drugs are known or reported to interact with this pseudogene.
07

Biomarkers

None known for clinical use or disease association.

Beyond the preview

Go deeper on Zinc finger protein 322 pseudogene 1 (ZNF322P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 322 pseudogene 1 (ZNF322P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call